Abstract
Comprehensive molecular profiling to identify genomic driver mutations is inconsistently performed for squamous (sq) non-small cell lung cancer (NSCLC). Thorough profiling of this, by smoking status, will help guide diagnostic and therapeutic decision-making.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
